Service profile
Syndax Pharmaceuticals
Biopharmaceutical company developing cancer therapies with clinical-stage programs targeting entinostat for breast cancer and SNDX-5613 for leukemias, focused on epigenetic regulation and immunotherapy combinations for solid tumors and blood cancers.
About
What Syndax Pharmaceuticals is
Biopharmaceutical company developing cancer therapies with clinical-stage programs targeting entinostat for breast cancer and SNDX-5613 for leukemias, focused on epigenetic regulation and immunotherapy combinations for solid tumors and blood cancers.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://syndaxpharmaceuticals.com |
| Status coverage | Public status page |
| Founded | 2005 |
| Headquarters | Waltham, Massachusetts, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...